Unified Quantum Mechanical Picture for Confined Spinons in Dimerized and Frustrated Spin S=1/2 Chains

A quantum mechanical picture is presented to describe the behavior of confined spinons in a variety of S=1/2 chains. The confinement is due to dimerization and frustration and it manifests itselfas a nonlinear potential V(x)~ |x|^b, centered at chain ends (b <= 1) or produced by modulation kinks (b > 1). The calculation extends to weak or zero frustration some previous ideas valid for spinons in strongly frustrated spin chains. The local magnetization patterns of the confined spinons are calculated. A (minimum) enhancement of the local moments of about 11/3 over a single S=1/2 is found. Estimates for excitation energies and binding lengths are obtained.Comment: 11.5 pages, Revtex, 10 figures included, accepted by Euro. Phys. J. B final version including some changes, several references adde

Enhancement of Antiferromagnetic Correlations Induced by Nonmagnetic Impurities: Origin and Predictions for NMR Experiments

Spin models that have been proposed to describe dimerized chains, ladders, two dimensional antiferromagnets, and other compounds are here studied when some spins are replaced by spinless vacancies, such as it occurs by $Zn$ doping. A small percentage of vacancies rapidly destroys the spin gap, and their presence induces enhanced antiferromagnetic correlations near those vacancies. The study is performed with computational techniques which includes Lanczos, world-line Monte Carlo, and the Density Matrix Renormalization Group methods. Since the phenomenon of enhanced antiferromagnetism is found to occur in several models and cluster geometries, a common simple explanation for its presence may exist. It is argued that the resonating-valence-bond character of the spin correlations at short distances of a large variety of models is responsible for the presence of robust staggered spin correlations near vacancies and lattice edges. The phenomenon takes place regardless of the long distance properties of the ground state, and it is caused by a ``pruning'' of the available spin singlets in the vicinity of the vacancies. The effect produces a broadening of the low temperature NMR signal for the compounds analyzed here. This broadening should be experimentally observable in the structurally dimerized chain systems $Cu(NO_3)_2\cdot2.5H_2O$, $CuWO_4$, $(VO)_2P_2O_7$, and $Sr_{14}Cu_{24}O_{41}$, in ladder materials such as $Sr Cu_2 O_3$, in the spin-Peierls systems $CuGeO_3$ and $NaV_2 O_5$, and in several others since it is a universal effect common to a wide variety of models and compounds.Comment: 18 pages revtex with 26 figures include

Individual Oral Therapy with Immediate Release and Effervescent Formulations Delivered by the Solid Dosage Pen

New devices enabling freely selectable dosing of solid oral medications are urgently needed for personalized medicine. One approach is the use of the recently published Solid Dosage Pen, allowing flexible dosing of tablet-like sustained release slices from drug loaded extruded strands. Slices were suitable for oral single dosed application. The aim of the present study was the development of immediate release dosage forms for applications of the device, especially for young children. Using two model drugs, two different concepts were investigated and evaluated. Effervescent formulations were manufactured by an organic wet-extrusion process and immediate release formulations by a melt-extrusion process. Dissolution experiments were performed for both formulations to ensure the immediate release behavior. Extruded strands were individually dosed by the Solid Dosage Pen. Various doses of the two formulations were analyzed regarding uniformity of mass and content according to pharmacopoeial specifications. Proof of concept was demonstrated in both approaches as results comply with the regulatory requirements. Furthermore, storing stress tests were performed and drug formulations were characterized after storing. The results show that suitable packaging material has been selected and storage stability is probable

Dual-Energy CT-derived Iodine Maps: Use in Assessing Pleural Carcinomatosis

Purpose: To evaluate the use of spectral CT for differentiation between noncalcified benign pleural lesions and pleural carcinomatosis. Materials and Methods: In this retrospective study, patients who underwent contrast agent-enhanced late venous phase spectral CT of the chest between June 1, 2016, and July 1, 2018 with histopathologic and/or imaging confirmation of noncalcified pleural lesions were evaluated. Conventional images, iodine overlay (IO) images, and virtual monoenergetic images at 40 keV (hereafter, VMI40keV) were reconstructed from contrast-enhanced spectral chest CT. Four blinded radiologists determined lesion presence and indicated lesion conspicuity and diagnostic certainty. Hounsfield unit attenuation from conventional images and iodine concentration (IC) (in milligrams per milliliter) from IO images were determined. Area under the receiver operating characteristics curve determined thresholds for quantitative lesion differentiation and cutoff values were validated in an independent data set. Results: Eighty-four patients were included (mean age, 66.2 years; 54 men and 30 women; 44 patients with cancer with confirmed pleural carcinomatosis and 40 patients with benign pleural lesions). The area under the receiver operating characteristics curve for IC was greater than that of conventional Hounsfield units (0.96 vs 0.91; P <= .05, respectively). The optimal IC threshold was 1.3 mg/mL, with comparable sensitivity and specificity when applied to the test data set. The sensitivities to depict pleural carcinomatosis with spectral reconstructions versus conventional CT were 96% (199 of 208) and 83% (172 of 208), respectively, with specificities of 84% (161 of 192) and 63% (120 of 192), respectively (P <= .001 each). Conclusion: Compared with conventional images, spectral CT with iodine maps improved both quantitative and qualitative determination of pleural carcinomatosis versus noncalcified benign pleural lesions. (C) RSNA, 201

Metal implants on abdominal CT: does split-filter dual-energy CT provide additional value over iterative metal artifact reduction?

Purpose To assess image quality and metal artifact reduction in split-filter dual-energy CT (sfDECT) of the abdomen with hip or spinal implants using virtual monoenergetic images (VMI) and iterative metal artifact reduction algorithm (iMAR). Methods 102 portal-venous abdominal sfDECTs of patients with hip (n = 71) or spinal implants (n = 31) were included in this study. Images were reconstructed as 120kVp-equivalent images (Mixed) and VMI (40-190 keV), with and without iMAR. Quantitative artifact and image noise was measured using 12 different ROIs. Subjective image quality was rated by two readers using a five- point Likert-scale in six categories, including overall image quality and vascular contrast. Results Lowest quantitative artifact in both hip and spinal implants was measured in VMI190keV-iMAR. However, it was not significantly lower than in Mixed(iMAR) (for all ROIs, p = 1.00), which were rated best for overall image quality (hip: 1.00 [IQR: 1.00-2.00], spine: 3.00 [IQR:2.00-3.00]). VMI50keV- iMAR was rated best for vascular contrast (hip: 1.00 [IQR: 1.00-2.00], spine: 2.00 [IQR: 1.00-2.00]), which was significantly better than Mixed (both, p < 0.001). VMI50keV-iMAR provided superior overall image quality compared to Mixed for hip (1.00 vs 2.00, p < 0.001) and similar diagnostic image quality for spinal implants (2.00 vs 2.00, p = 0.51). Conclusion For abdominal sfDECT with hip or spinal implants Mixed(iMAR) images should be used. High keV VMI do not further improve image quality. IMAR allows the use of low keV images (VMI50keV) to improve vascular contrast, compared to Mixed images

CT metal artifacts in patients with total hip replacements: for artifact reduction monoenergetic reconstructions and post-processing algorithms are both efficient but not similar

Objectives This study compares metal artifact (MA) reduction in imaging of total hip replacements (THR) using virtual monoenergetic images (VMI), for MA-reduction-specialized reconstructions (MAR) and conventional CT images (CI) from detector-based dual-energy computed tomography (SDCT). Methods Twenty-seven SDCT-datasets of patients carrying THR were included. CI, MAR and VMI with different energy-levels (60-200 keV) were reconstructed from the same scans. MA width was measured. Attenuation (HU), noise (SD) and contrast-to-noise ratio (CNR) were determined in: extinction artifact, adjacent bone, muscle and bladder. Two radiologists assessed MA-reduction and image quality visually. Results In comparison to CI, VMI (200 keV) and MAR showed a strong artifact reduction (MA width: CI 29.9 +/- 6.8 mm, VMI 17.6 +/- 13.6 mm, p<0.001; MAR 16.51 +/- 4.9 mm, p<0.001; MA density: CI -412.1 +/- 204.5 HU, VMI -279.7 +/- 283.7 HU; p<0.01; MAR -116.74 +/- 105.6 HU, p<0.001). In strong artifacts reduction was superior by MAR. In moderate artifacts VMI was more effective. MAR showed best noise reduction and CNR in bladder and muscle (p<0.05), whereas VMI were superior for depiction of bone (p<0.05). Visual assessment confirmed that VMI and MAR improve artifact reduction and image quality (p<0.001). Conclusions MAR and VMI (200 keV) yielded significant MA reduction. Each showed distinct advantages both regarding effectiveness of artifact reduction, MAR regarding assessment of soft tissue and VMI regarding assessment of bone

Dual-layer detector CT of the head: Initial experience in visualization of intracranial hemorrhage and hypodense brain lesions using virtual monoenergetic images

Purpose: Retrospective comparison of diagnostic quality of virtual monoenergetic images (VMI) and conventional images (CI) reconstructed from dual-layer detector CT (DLCT) regarding intraparenchymal hemorrhage (IPH) and hypodense parenchymal lesions (HPL) of the brain. Methods: 58 patients underwent unenhanced DLCT of the head. CI and VMI ranging from 40 to 120 keV were reconstructed. Objective image quality was assessed using ROI-based measurements within IPH, HPL, grey matter, white matter and cerebrospinal fluid, from which contrast to noise ratio (CNR) was calculated. Two radiologists assessed IPH, HPL, artifacts and image noise on a 5-point Likert-scale. Statistical significance was determined using Wilcoxon rank sum test. Results: In comparison to conventional images, CNR of HPL to white matter was significantly increased in VMI at 120 keV (p <= 0.01), whereas at 40 keV, CNR to grey matter was enhanced (p <= 0.0001). Contrary, CNR of IPH to white matter was increased at 40 keV (p <= 0.01), while CNR to grey matter was improved at 120 keV (p <= 0.01). Subjective readings confirmed best delineation of IPH within grey matter at 120 keV. Both readers detected four additional hyperdense lesions within white and one within grey matter at 40 keV. Conclusions: VMI obtained with DLCT can improve depiction of hypodense parenchymal lesions and intraparenchymal hemorrhage. The initial data show a great dependency on the type of pathology and on its location: hypodense lesions in white matter and hyperdense lesions in grey matter are better visualized in higher keV reconstructions, while hyperdense lesion in white matter and hypodense lesions in grey matter are better visualized at low keV values

Iodine accumulation of the liver in patients treated with amiodarone can be unmasked using material decomposition from multiphase spectral-detector CT

Amiodarone accumulates in the liver, where it increases x-ray attenuation due to its iodine content. We evaluated liver attenuation in patients treated and not treated with amiodarone using true-non-contrast (TNC) and virtual-non-contrast (VNC) images acquired with spectral-detector-CT (SDCT). 142 patients, of which 21 have been treated with amiodarone, receiving SDCT-examinations (unenhanced-chest CT [TNC], CT-angiography of chest and abdomen [CTA-Chest, CTA-Abdomen]) were included. TNC, CTA-Chest, CTA-Abdomen, and corresponding VNC-images (VNC-Chest, VNC-Abdomen) were reconstructed. Liver-attenuation-index (LAI) was calculated as difference between liver- and spleen-attenuation. Liver-attenuation and LAI derived from TNC-images of patients receiving amiodarone were higher. Contrary to TNC, liver-attenuation and LAI were not higher in amiodarone patients in VNC-Chest and in VNC-Abdomen. To verify these initial results, a phantom scan was performed and an additional patient cohort included, both confirming that VNC is viable of accurately subtracting iodine of hepatic amiodarone-deposits. This might help to monitor liver-attenuation more accurately and thereby detect liver steatosis as a sign of liver damage earlier as well as to verify amiodarone accumulation in the liver